Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
TRVI (Trevi Therapeutics, Inc.) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Prev close 15.05 · gapped above the open, then crossed back over prior close. High/low 16.16 at 4:15 am ET, 14.81 at 11:15 am ET.
Trevi Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
219 institutional managers report a position in Trevi Therapeutics, Inc. worth $2.8B between them, filed on form 13F for the quarter ending 2026-06-30. 33 of them hold 80% of it, the largest being NEA Management Company, LLC at 8.79%.
194 more managers in the register
33 managers hold 80% of the $2.8B institutional base. The other 186 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Woodline Partners LP +13 more · 8.79% of TRVI, 11.26% of SVRA
via Frazier Life Sciences Management, L.P., NEA Management Company, LLC, Wellington Management Group LLP +6 more · 6.61% of TRVI, 11.86% of MBX
via Frazier Life Sciences Management, L.P., Woodline Partners LP, Frontier Capital Management Co LLC +9 more · 6.61% of TRVI, 6.06% of PVLA
via Wellington Management Group LLP, Frazier Life Sciences Management, L.P., Woodline Partners LP +9 more · 3.78% of TRVI, 4.03% of IRON
via Frazier Life Sciences Management, L.P., Vivo Capital, LLC, Marshall Wace LLP +6 more · 6.61% of TRVI, 8.98% of ACHV
via NEA Management Company, LLC, Vestal Point Capital, LP, Marshall Wace LLP +5 more · 8.79% of TRVI, 8.25% of GLUE
Managers holding a meaningful stake in TRVI also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.